Related Experiment Video
Updated: Jul 2, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Sneddon-Wilkinson disease treated with etanercept: report of two cases
1Department of Internal Medicine, Division of Dermatology, Washington University School of Medicine, St Louis, MO 63110, USA. dberk@im.wustl.edu
Abstract:
Sneddon-Wilkinson disease (SWD), also known as subcorneal pustular dermatosis, is a rare, chronic eruption that is often difficult to treat, particularly in patients who do not respond to or cannot tolerate dapsone. Few case reports exist of patients with SWD treated with antitumour necrosis factor-alpha therapy. We report two patients with SWD refractory to numerous treatments, who responded to etanercept (in combination with low-dose acitretin in one case).
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drug Toxicity: Allergic Reactions
Nephrotic Syndrome III : Nursing Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents